Filing Details
- Accession Number:
- 0001127602-18-021961
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-06-27 17:14:54
- Reporting Period:
- 2018-06-25
- Accepted Time:
- 2018-06-27 17:14:54
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
313143 | Haemonetics Corp | HAE | Surgical & Medical Instruments & Apparatus (3841) | 042882273 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1682069 | Mr. P. William Burke | 400 Wood Road Braintree MA 02184 | Evp, Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-06-25 | 5,717 | $41.64 | 21,291 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-06-25 | 5,717 | $92.17 | 15,574 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-06-25 | 970 | $92.17 | 14,604 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2018-06-25 | 5,717 | $0.00 | 5,717 | $41.64 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
17,153 | 2018-06-06 | 2024-06-06 | No | 4 | M | Direct |
Footnotes
- Transaction pursuant to an existing 10b5-1 trading plan.
- This number includes unvested restricted stock units previously reported.
- Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.